American scientists have found that the experimental drug Molnupiravir reduces the level of infectious virus in the early stages of the disease.
An experimental drug for the treatment of coronavirus is being tested in the United States, which has been shown to be highly effective at an early stage of the disease during testing. This is stated in a statement by the American drug manufacturer Merck, according to USA Today.
It is reported that the drug Molnupiravir showed a rapid decrease in the level of infectious virus in patients at an early stage of the disease.
The drug was tested in more than 200 hospitalized patients, all of whom had faster reductions in viral infectivity than those in the placebo group.
The lead researcher at the University of North Carolina School of Medicine, William Fisher, called the research results promising, but more research needs to confirm them.
Molnupiravir is an experimental oral active antiviral drug developed for the treatment of influenza.
Note, recently, China approved the entry into the market of three drugs of traditional Chinese medicine for the treatment of coronavirus.